TCL Archive After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA April 14, 1995
TCL Archive Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease April 25, 2014
TCL Archive BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women November 3, 1978